Friess Associates Llc decreased Albemarle Corp. (ALB) stake by 1.79% reported in 2017Q2 SEC filing. Friess Associates Llc sold 3,159 shares as Albemarle Corp. (ALB)’s stock rose 20.02%. The Friess Associates Llc holds 172,892 shares with $18.25 million value, down from 176,051 last quarter. Albemarle Corp. now has $14.60B valuation. The stock decreased 1.62% or $2.17 during the last trading session, reaching $132.15. About 1.24M shares traded. Albemarle Corporation (NYSE:ALB) has risen 45.60% since December 2, 2016 and is uptrending. It has outperformed by 28.90% the S&P500.
International MA Divers Inc ETF (YDIV) formed wedge down with $17.40 target or 5.00% below today’s $18.32 share price. International MA Divers Inc ETF (YDIV) has $13.81M valuation. The ETF decreased 1.73% or $0.322 during the last trading session, reaching $18.318. About 1,751 shares traded. International MA Divers Inc ETF (NASDAQ:YDIV) has risen 2.14% since December 2, 2016 and is uptrending. It has underperformed by 14.56% the S&P500.
Friess Associates Llc increased Evolent Health Inc. stake by 183,163 shares to 393,163 valued at $9.97 million in 2017Q2. It also upped Zoetis Inc. (NYSE:ZTS) stake by 45,000 shares and now owns 305,000 shares. Kosmos Energy Ltd. (NYSE:KOS) was raised too.
Analysts await Albemarle Corporation (NYSE:ALB) to report earnings on February, 26. They expect $1.18 EPS, up 51.28% or $0.40 from last year’s $0.78 per share. ALB’s profit will be $130.38M for 28.00 P/E if the $1.18 EPS becomes a reality. After $1.08 actual EPS reported by Albemarle Corporation for the previous quarter, Wall Street now forecasts 9.26% EPS growth.
Among 20 analysts covering Albemarle Corporation (NYSE:ALB), 10 have Buy rating, 0 Sell and 10 Hold. Therefore 50% are positive. Albemarle Corporation had 59 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Albemarle Corporation (NYSE:ALB) earned “Buy” rating by KeyBanc Capital Markets on Monday, October 16. The stock has “Buy” rating by Citigroup on Tuesday, August 9. Oppenheimer maintained the stock with “Buy” rating in Thursday, November 9 report. RBC Capital Markets maintained Albemarle Corporation (NYSE:ALB) on Friday, March 17 with “Outperform” rating. The firm earned “Buy” rating on Thursday, August 20 by Deutsche Bank. Suntrust Robinson downgraded Albemarle Corporation (NYSE:ALB) on Wednesday, August 9 to “Hold” rating. The firm earned “Buy” rating on Monday, August 21 by Jefferies. As per Tuesday, December 29, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Monday, October 23 by Jefferies. The firm earned “Buy” rating on Friday, June 16 by Jefferies.
Since June 19, 2017, it had 0 insider purchases, and 2 selling transactions for $3.24 million activity. On Monday, June 19 the insider Maine Douglas L sold $1.08 million. $2.16M worth of Albemarle Corporation (NYSE:ALB) was sold by NARWOLD KAREN G.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.